Skip to main content

Table 3 V γ 9/V δ 2 expansion factor to several different phosphoantigens in vitro

From: Predominance of Vγ9/Vδ2 T Lymphocytes in the Cerebrospinal Fluid of Children with Tuberculous Meningitis: Reversal after Chemotherapy

Group

Source

Vγ9/Vδ2 EF after In Vitro Culture with

Rib-1-P

Xyl-1-P

IPP

DMAPP

TUBAg

TBM patients

      

1

CSF

14

13

24

28

35

 

PBMC

7

2

5

6

8

2

CSF

38

30

61

54

68

 

PBMC

22

12

30

28

40

3

CSF

15

10

40

30

64

 

PBMC

10

8

32

26

44

4

CSF

17

21

44

49

79

 

PBMC

12

20

45

53

72

5

CSF

35

27

60

48

90

 

PBMC

20

18

34

40

54

6

CSF

15

17

78

80

143

 

PBMC

7

12

12

18

32

Controls

      

7

CSF

1

3

1

7

5

 

PBMC

1

1

2

4

5

8

CSF

3

1

2

10

5

 

PBMC

1

1

6

4

7

9

CSF

5

2

1

6

8

 

PBMC

6

7

ND

ND

5

10

CSF

3

7

7

4

2

 

PBMC

1

4

5

5

12

11

CSF

2

3

1

9

11

 

PBMC

2

4

4

7

7

12

CSF

5

6

8

8

11

 

PBMC

6

4

7

9

9

13

CSF

1

4

5

3

5

 

PBMC

3

7

7

9

14

  1. Paired samples of PBMC and CSF cells from children affected by TBM were stimulated in vitro with the indicated phosphoantigens, and the Vγ9/Vδ2 expansion factor (EF) was determined as described in Materials and Methods. ND, not determined.